3010

Hangzhou Bio-Sincerity Pharmaceutical Co., Ltd. (301096)

Market Closed
12 Dec, 06:57
XSHE XSHE
¥
54. 00
+0.8
+1.5%
¥
5.67B Market Cap
- P/E Ratio
1.2% Div Yield
2,227,100 Volume
- Eps
¥ 53.2
Previous Close
Day Range
53.03 55.09
Year Range
30.6 77.17
Want to track 301096 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

301096 closed Friday higher at ¥54, an increase of 1.5% from Thursday's close, completing a monthly increase of 0.24% or ¥0.13. Over the past 12 months, 301096 stock gained 42.26%.
301096 is not paying dividends to its shareholders.
The last earnings report, released on Oct 28, 2024, exceeded the consensus estimates by 0.07%. On average, the company has surpassed earnings expectations by 0.43%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).

301096 Chart

Similar

Guangzhou Wondfo Biotech Co., Ltd.
¥ 20.04
-1.09%
China Reform Health Management Co., Ltd.
¥ 9.21
-1.6%
Acro Biosystems Co., Ltd.
¥ 54.17
-0.07%
EIT Environmental Development Group Co., Ltd.
¥ 21.96
+0.78%
Huapont Life Sciences Co., Ltd.
¥ 4.67
-0.64%

Hangzhou Bio-Sincerity Pharmaceutical Co., Ltd. (301096) FAQ

What is the stock price today?

The current price is ¥54.00.

On which exchange is it traded?

Hangzhou Bio-Sincerity Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 301096.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.2%.

What is its market cap?

As of today, the market cap is 5.67B.

Has Hangzhou Bio-Sincerity Pharmaceutical Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Hangzhou Bio-Sincerity Pharmaceutical Co., Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
Ms. Jinfang Lou CEO
XSHE Exchange
CNE1000056N5 ISIN
China Country
1,834 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd., founded in 2011 and based in Hangzhou, China, is a pharmaceutical technology research, development, and services enterprise. The company plays a crucial role in the pharmaceutical industry by focusing on various phases of drug research and development. Its operations span across the essential processes of drug discovery, including pharmaceutical research, clinical trials, customized research and development and production, and the application for product registration. Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. is committed to transforming research and development technology results, catering to pharmaceutical and pharmaceutical research and development investment companies across China.

Products and Services

  • Drug Research and Development Services:

    Offers comprehensive services in the initial stages of drug discovery, facilitating the development of pharmaceuticals through innovative research methodologies and cutting-edge technologies.

  • Transformation of Research and Development Technology Results:

    Specializes in transforming the outcomes of pharmaceutical research into tangible, market-ready products, ensuring that new discoveries are rapidly and efficiently brought to market.

  • Pharmaceutical Research and Development Investment:

    Provides investment opportunities in the pharmaceutical research and development sector, supporting the advancement of new and existing pharmaceutical products.

  • Customized Research and Development and Production:

    Offers tailored research and development services that meet the specific needs of their clients, including customized production processes to ensure the highest quality of pharmaceutical products.

  • Registration Applications:

    Assists in the preparation and submission of registration applications for new drugs, ensuring compliance with regulatory standards and facilitating the approval process.

Contact Information

Address: Jinsheng Science and Technology Park
Phone: 86 571 8792 3909